# ALX Oncology Holdings Inc: Form 8-K, filed Mar 7, 2024

- Company: [ALX Oncology Holdings Inc](/companies/alxo.md) (CIK 1810182)
- Form: 8-K
- Filed: 2024-03-07
- Accepted by EDGAR: Mar 7, 2024, 21:05 ET
- Period: 2024-03-07
- Accession: 0000950170-24-027925
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1810182/000095017024027925/alxo-20240307.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810182/000095017024027925/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810182/000095017024027925/alxo-20240307.htm

Filed Mar 7, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-027925. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.